BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Hallervorden-Spatz Syndrome

Below is an extended Hallervorden-Spatz Syndrome research listing. Click here to return to the Hallervorden-Spatz Syndrome main in depth entry.

Recent Publications on Hallervorden-Spatz Syndrome:

Pantothenate kinase-associated neurodegeneration in two Chinese children: identification of a novel PANK2 gene mutation. 9th April, 2008
Department of Paediatrics and Adolescent Medicine, Princess Margaret
Deprivation of pantothenic acid elicits a movement disorder and azoospermia in a mouse model of pantothenate kinase-associated neurodegeneration.
We asked whether a movement disorder could be elicited by deprivation of...
Direct Link
19th August, 2007
Department of Medicine, University of California, San Francisco, CA, USA.
Neurodegeneration with brain iron accumulation: clinical, radiographic and genetic heterogeneity and corresponding therapeutic options. 21st July, 2007
Department of Neurology, Hopital Roger Salengro, Lille, France.
Relaxation and susceptibility MRI characteristics in Hallervorden-Spatz syndrome.
PURPOSE: To evaluate the imaging characteristics of the brain with respect...
Direct Link
7th June, 2007
Department of Neuroimaging and Interventional Radiology, National
Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations. 23rd August, 2006
Department of Molecular and Medical Genetics, School of Medicine, Oregon
A novel 3-bp deletion in the PANK2 gene of Dutch patients with pantothenate kinase-associated neurodegeneration: evidence for a founder effect.
Mutation analysis was performed in four apparently unrelated Dutch...
Direct Link
15th August, 2006
Department of Clinical Genetics, University Medical Centre Groningen,
Clinical heterogeneity in Hallervorden-Spatz syndrome: a clinicoradiological study in 13 patients from South India.
Hallervorden-Spatz syndrome (HSS) is a rare autosomal recessive...
Direct Link
1st August, 2006
Department of Neurology, National Institute of Mental Health and
Dietary rescue of fumble--a Drosophila model for pantothenate-kinase-associated neurodegeneration.
Hallervorden-Spatz syndrome (HSS) is a devastating neurological disease,...
Direct Link
6th July, 2006
Department of Biological Sciences and Biotechnology, Tsinghua University,
Tau-predominant-associated pathology in a sporadic late-onset Hallervorden-Spatz syndrome.
Hallervorden-Spatz syndrome (HSS) is a heterogeneous clinicopathological...
Direct Link
4th July, 2006
Neurology Service, Hospital de Cruces, Department of Neurosciences,
Neurodegeneration with brain iron accumulation. 25th April, 2006
Department of Molecular and Medical Genetics, Oregon Health & Science
Diagnostic significance of reduced serum caeruloplasmin concentration in neurological disease.
This study covers patients seen at a Wilson disease clinic between 1960...
Direct Link
22nd March, 2006
Department of Neurology, The Middlesex Hospital, London, UK.
Status Dystonicus: study of five cases.
Status Dystonicus (SD) is characterized by generalized muscle contractions...
Direct Link
6th January, 2006
Servico de Neurologia, Hospital de Clinicas, Universidade Federal do
First cases in the Czech Republic of the Hallervorden-Spatz disease resulting from mutation in the pantothenate kinase 2 gene. 6th October, 2005
Neurogenetic Centre, 2nd Faculty of Medicine of Charles University and
The eye-of-the-tiger sign is not a reliable disease marker for Hallervorden-Spatz syndrome.
Pantothenate kinase-associated neurodegeneration (PKAN), formerly...
Direct Link
30th September, 2005
Children's Hospital of the Technical University Munich, Munich, Germany.
Neuro-ophthalmologic and electroretinographic findings in pantothenate kinase-associated neurodegeneration (formerly Hallervorden-Spatz syndrome).
PURPOSE: The onset of pantothenate kinase-associated neurodegeneration...
Direct Link
1st September, 2005
Casey Eye Institute, Department of Ophthalmology, Oregon Health & Science
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional